0001127602-14-015512.txt : 20140429 0001127602-14-015512.hdr.sgml : 20140429 20140429175927 ACCESSION NUMBER: 0001127602-14-015512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140425 FILED AS OF DATE: 20140429 DATE AS OF CHANGE: 20140429 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Piacquad David CENTRAL INDEX KEY: 0001602343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 14795293 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-04-25 0000318154 AMGEN INC AMGN 0001602343 Piacquad David ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 SVP, Business Development Common Stock 2014-04-25 4 F 0 320 113.72 D 26707 D Common Stock 2014-04-25 4 A 0 1166 0 A 27873 D Common Stock 2014-04-27 4 F 0 259 111.41 D 27614 D Common Stock 2014-04-27 4 F 0 10 111.41 D 27604 D The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 4/25/2016, 4/25/2017 and 4/25/2018. These shares include the following RSUs granted under the Company's equity plans: 3,750 RSUs which fully vest on 8/3/2014; 632 RSUs which fully vest on 4/25/2015; 1,005 RSUs which vest in 2 annual installments of 495 on 4/27/2015 and 510 on 4/27/2016; 840 RSUs which vest in 2 equal installments of 277 each on 4/26/2015 and 4/26/2016 and one installment of 286 on 4/26/2017; and 9,226 RSUs which vest in 2 equal installments of 4,163 each on 4/26/2015 and 4/26/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 221 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. /s/ David A. Piacquad 2014-04-29